Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism

NCT04088292 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT04088292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04088292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism
Lead sponsor
Rigshospitalet, Denmark
Phase
Phase 3
Overall status
Active, not recruiting
Start date
June 6, 2019
Completion date
November 30, 2024
Enrollment
210 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary embolism